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“Spin” in wound care research: the reporting and
interpretation of randomized controlled trials
with statistically non-significant primary outcome
results or unspecified primary outcomes
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Abstract
Background: Spin in the reporting of randomized controlled trials, where authors report research in a way that
potentially misrepresents results and mislead readers, has been demonstrated in the broader medical literature.
We investigated spin in wound care trials with (a) no statistically significant result for the primary outcome and
(b) no clearly specified primary outcome.
Methods: We searched the Cochrane Wounds Group Specialised Register of Trials for randomized controlled trials
(RCTs). Eligible studies were: Parallel-group RCTs of interventions for foot, leg or pressure ulcers published in 2004 to
2009 (inclusive) with either a clearly identified primary outcome for which there was a statistically non-significant
result (Cohort A) or studies that had no clear primary outcome (Cohort B).
We extracted general study details. For both Cohorts A and B we then assessed for the presence of spin. For
Cohort A we used a pre-defined process to assess reports for spin. For Cohort B we aimed to assess spin by
recording the number of positive treatment effect claims made. We also compared the number of statistically
significant and non-significant results reported in the main text and the abstract looking specifically for spin in the
form of selective outcome reporting.
Results: Of the 71 eligible studies, 28 were eligible for Cohort A; of these, 71% (20/28) contained spin. Cohort B
contained 43 studies; of these, 86% (37/43) had abstracts that claimed a favorable treatment claim. Whilst 74%
(32/43) of main text results in Cohort B included at least one statistically non-significant result, this was not reflected
in the abstract where only 28% contained (12/43) at least one statistically non-significant result.
Conclusions: Spin is a frequent phenomenon in reports of RCTs of wound treatments. Studies without statistically
significant results for the primary outcome used spin in 71% of cases. Furthermore, 33% (43/132) of reports of
wound RCTs did not specify a primary outcome and there was evidence of spin and selective outcome reporting in
the abstracts of these. Readers should be wary of only reading the abstracts of reports of RCTs of wound
treatments since they are frequently misleading regarding treatment effects.
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Background
Randomized controlled trials (RCTs) are the best design
for assessing the relative effectiveness of interventions in
healthcare because, if well conducted, they provide un-
biased estimates of treatment effects. However, even
where RCTs are well conducted the way in which a trial
is reported is also important. Studies focusing on report-
ing have mainly considered methodological issues such
as the reporting of allocation concealment and blinding
[1,2]. Recently, however, there has also been a focus on
“spin” in trial reporting, whereby authors’ use of language
and emphasis on results for particular outcomes poten-
tially misleads readers [3-7]. As Boutron and colleagues
[5] describe it, spin may “result from ignorance … uncon-
scious bias, or wilful intent to deceive”. Whilst the concept
of spin has been discussed in the British Medical Journal
as far back as 1995 [8-11], and there have been a num-
ber of methodological reviews evaluating misleading
claims in published reports of either RCTs [12-14] or
systematic reviews [15], there has been little research
into spin per se.
Boutron and colleagues [5] recently developed a me-
thod for identifying and classifying spin in RCT reports.
They applied their approach to a cohort of medical jour-
nal published papers that reported statistically non-
significant differences for the primary outcome. The
authors reported that spin was present in the main text
of 61% (44/72) papers and 68% (49/72) of abstracts. A
number of further studies have observed spin in trial re-
ports. Vera-Badillo and colleagues [6], focusing on cli-
nical trials for women with breast cancer, reported that
59% (54/92) of studies that found a statistically non-
significant difference for the primary outcome result
contained spin in either the abstract or concluding state-
ment, while Vedula and colleagues [7] observed that
66% (8/12) trials of gabapentin contained spin as well as
providing a detailed account of how such spin was used
in the promotion of gabapentin for off-label purposes.
We were interested in assessing the amount, type and
level of spin in RCTs of treatments for wounds where
most interventions are devices (rather than drugs) for
which effectiveness data are not required for licensing
and use in Europe [16]. In this current study we aimed
to assess the prevalence of spin using the classification
of Boutron and colleagues [5] in a cohort of wound care
trials that reported no statistically significant difference.
We have previously drawn attention to the misleading
way in which research is referred to in wound product
marketing literature [17]. As an extension of Boutron
and colleagues [5] previous work, we also assessed the
prevalence of wound RCTs that did not clearly specify
the primary outcome in the trial report (to which the full
application of the methodology described by Boutron
and colleagues [5] is not possible).
Specification of primary outcomes is required by
CONSORT (Consolidated Standards of Reporting Trials)
[1] and non-specification may be related to outcome
reporting bias (where outcomes are selected for report
on the basis of statistical significance). This phenomenon
has not been previously assessed in wounds research
though it is not uncommon in other areas [2]. We anti-
cipated non-specification of a primary outcome may be
common in wounds research since there is a range of
different outcome measures used including different
measures of wound healing (for example, reduction in
size versus complete healing) and no agreed core out-
comes [18,19].
Where trialists report multiple outcomes without
defining a primary outcome, we sought to test the hy-
pothesis that ‘spin’ resulting from selective outcome
reporting might be present – that is, the ‘cherry-picking’
of particular results to which extra emphasis is added
within the study report (for example, over-emphasis on
positive treatment effects). In particular, we sought to in-
vestigate whether statistically significant outcomes might
be more frequently presented in abstracts to the exclu-
sion of non-significant outcomes.
Methods
Eligibility, search and study selection
Eligible studies were: randomized evaluations of any in-
terventions for treatment of foot, leg or pressure ulcers;
reports published between 2004 and 2009, inclusive;
English language only (because of lack of translation re-
sources); and studies with a clearly specified primary
outcome with a statistically non-significant difference for
this treatment effect (defined as P = >0.05; classified as
Cohort A) or studies with no primary outcome specified
independent of its statistical significance (classified as
Cohort B).
We confined our study to RCTs of leg, foot and pres-
sure ulcer treatments since these are the most common
types of chronic wound and there is an identifiable
research community to whom the findings will be mea-
ningful and relevant. The 5-year window of trial publica-
tions was selected in order to manage limited resources
and the years 2004 to 2009 chosen as 2004 is 10 years
after the first paper on trial reporting quality and there-
fore there had been sufficient time for reporting quality
to improve [20].
Studies reported were considered to have specified a
primary outcome where they explicitly defined a primary
outcome in the introduction or methods section; re-
ported use of an outcome in a power calculation; or
where only a single outcome was reported. Studies with
multiple primary outcomes were considered not to have
identified a primary outcome and were included in
Cohort B. Following Boutron and colleagues [5], only
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studies with a statistically non-significant result for a
clearly specified primary outcome were included because
the interpretation of these results is more likely to be
subject to prior beliefs of effectiveness, resulting in
biased interpretations [5]. Phase 1 trials and equiva-
lence/non-inferiority trials were excluded since the aim
of the former is not to test effectiveness and in the latter
P values are not interpretable in the same way as a su-
periority trial. Trials described as pilot studies were also
excluded if their objective was clearly to investigate the
feasibility of a full trial, as were all conference abstracts.
Studies were also excluded if they were secondary re-
ports where the primary paper or main study report was
referenced, or where it was clear it was a protocol or
economic evaluation.
Studies were identified by searching the Cochrane
Wounds Group Specialised Register of Trials (Cochrane
Wounds Group resource). The register is maintained by
the Cochrane Wounds Group, York, and aims to identify
all randomized and quasi-randomized controlled trials in
the area of wounds research. Reports are identified for
inclusion in the register by regular searches of a number
of databases including Medline, Embase, CINAHL and
Central along with periodic searches of other databases.
Studies included in the register have been coded on
several criteria including wound type. A search was
therefore carried out on publications in 2004 to 2009
(inclusive) using the following search terms in the con-
dition field: Pressure* or Venous or Leg* or Ulcer* or
Diabet*, and in the intervention field: Treat*.
The titles and abstracts (where available) of identified
studies were screened by a single author (JCD) to ex-
clude obviously irrelevant studies, based on the above
eligibility criteria. The full text of the remaining papers
was screened by two authors (RH and SL) after extensive
piloting of the screening criteria and extraction form.
Any disagreements were resolved through discussion
and arbitrated by a third author (JCD) where agreement
could not be reached.
Data extraction
General
The development of the data extraction sheet was a
process of iteration involving discussion between the
three reviewers (JCD, RH, SL), with piloting at each
stage.
For both Cohorts A and B the following general cha-
racteristics were extracted: wound type; number of trial
arms; intervention and comparator(s); duration of follow-
up; and funding source.
Data extraction was recorded on a Microsoft Excel
spreadsheet using drop-down menus where appropriate.
Data extraction was completed independently by two re-
viewers (SL, RH), with disagreements resolved through
discussion and involvement of a third reviewer (JCD)
where required. Kappa statistics were calculated.
Cohort A: studies with a statistically non-significant
difference for the primary outcome result
This part of the study followed the methodology of
Boutron and colleagues [5]. We applied the spin classifica-
tion scheme to the following sections of each study in Co-
hort A: abstract results and conclusions sections; and
main text results, discussion and conclusions sections
(where there was no clear conclusion section the last para-
graph that summarized the results was used).
In addition to identifying and classifying spin per se,
we also assessed the level of spin in the abstract and
main text conclusions according to Boutron and col-
leagues [5]. Boutron and colleagues [5] employed three
schemes, one applied to the results sections (abstract
and main text); one applied to the discussion section;
and one applied to the conclusions sections (abstract
and main text). These are as follows:
Results
 Focus on statistically significant within-group
comparison
 Focus on significant secondary outcomes
 Focus on significant subgroup
 Focus on significant modified population
(for example, per protocol)
 Focus on statistically significant within- and
between-group comparisons of secondary outcomes
 Anything that at the discretion of the authors was
considered to be spin and is not covered by the
above categories
Discussion
 Focus on statistically significant within-group
comparison
 Focus on significant secondary outcomes
 Focus on significant subgroup
 Focus on significant modified population
(for example, per protocol)
 Claims equivalence
 Rules out adverse effect
Conclusion
 Claims effectiveness with no acknowledgement of
non-significant results for primary outcome
 Claims equivalence
 Rules out adverse effect
 Acknowledges non-significance, but emphasizes
significant results for other outcomes
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 Acknowledges non-significance, but emphasizes
treatment benefit
 Emphasizes benefit based on new outcome
 Anything that at the discretion of the authors was
considered to be spin and is not covered by the
above categories
The level of spin was classified as high, moderate, low
or none according to the following criteria, with none
acting as a default category:
 High spin: no acknowledgement of non-significant
results for primary outcome and no uncertainty in
framing and no recommendations for further trials
 Moderate spin: no acknowledgement of non-
significant result for primary outcome and
uncertainty in framing or recommendations for
further trials
 Low spin: acknowledgement of non-significant
results for primary outcome, but uncertainty in
framing and recommendations for further trials
Cohort B: studies with no clearly defined primary outcome
Within Cohort B we counted the number of outcomes
reported in the main text and abstract and then extrac-
ted the statistical significance of findings for each out-
come and classified them as: significant (using P < 0.05)
or not statistically significant (P ≥ 0.05). Where no sta-
tistical testing was conducted or clearly reported the
statistical significance of the treatment effect was re-
corded as unclear. In addition, we recorded whether the
abstract claimed an effect (that is, a positive claim about
a treatment effect).
Data analysis
Results were initially recorded in Microsoft Excel, and
SPSS (Released 2009. PASW Statistics for Windows,
Version 18.0. Chicago: SPSS Inc.) [21] was used for data
analysis.
Cohort A: studies with statistically non- significant
differences for the primary outcome
Descriptive summary statistics (number and percentage
for categorical data; median, range and inter-quartile
range for continuous data) were calculated for: the gen-
eral characteristics of included studies (nature of funder,
wound type, duration of follow up, intervention and
comparator(s)); stratified by outcome type (continuous
versus dichotomous), the prevalence of spin overall, and
by section of the paper (that is, abstract, main results,
main discussion and main conclusion); the types of spin
used in each section of the paper; and the level of spin
in the abstract and main text conclusions.
75 studies excluded:
24 secondary reports
2 protocols
2 economic evaluations
28 wound type
11 not RCT
8 study design
71 reports eligible for inclusion
Cohort A
28 studies with a 
statistically non - 
significant 
primary 
outcome
Cohort B
43 studies with 
unspecified 
primary outcome
Reports of 207 studies screened for initial
eligibility 
61 studies excluded
56 statistically significant 
results for clearly defined 
primary outcome
5 primary outcomes defined 
but result not 
analysed/reported
Title and abstracts of 519 studies screened
for eligibility
312 studies excluded
132 reports of RCTS of treatments for leg, foot and
pressure ulcer
Figure 1 Review summary.
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Cohort B: studies with no specified primary outcome
Descriptive summary statistics were calculated for: the
general characteristics of included studies (number and
percentage for categorical; median, range and interquar-
tile range for continuous); summary of outcomes re-
ported in the results section of the main text and the
abstract, with comparison of the proportion of statis-
tically significant findings in each; and number (pro-
portion) of studies claiming a treatment effect in the
abstract.
Results
Of the 207 original study reports, 132 were primary re-
ports of RCTs of interventions for leg, foot and pressure
ulcers of which 71 met our inclusion criteria (Figure 1)
(Additional file 1) – all study reports described only one
relevant RCT. Twenty-eight studies reported a statisti-
cally non-significant result for the primary outcome and
were analyzed for presence of spin (Cohort A) and 43
studies did not specify a primary outcome (Cohort B).
Cohort A: studies with a statistically non-significant
difference for the primary outcome
Agreement with regards to the extraction was fair to
good, with Kappa statistics of 0.62, 0.74, 0.65, 0.75 and
0.76, respectively, for each of the following sections:
abstract discussion, abstract conclusions, main report re-
sults, main report discussion and main report conclu-
sions. Recourse to a third reviewer was required only
three times. Table 1 summarizes the characteristics of
the studies in Cohort A.
Cohort A: prevalence and type of spin in the abstract and
main text
In total, 63% (17/27) of abstracts contained spin (one
study had no abstract) with 30% (8/27) of abstracts
claiming effectiveness of the intervention. A further 22%
of abstracts (6/27) acknowledged the non-significant re-
sult for the primary outcome, but emphasized other sig-
nificant results. Over half of the abstract conclusions
contained spin (59%; 16/27).
Nearly three-quarters (71%) of reports contained spin
in the main text (that is, spin in any category; Table 2).
The prevalence of spin was highest in the main text con-
clusions (61%; 17/28) where the most common forms of
spin were claims of equivalence or effectiveness without
acknowledging that there was no statistically significant
difference for the primary outcome. In some cases, mul-
tiple types of spin were used. We also observed that
emphasis on secondary outcomes both within the results
and discussion section was only adopted when the pri-
mary outcome was a continuous one.
Cohort A: level of spin
The overall prevalence of spin in the abstract and main
text conclusions was comparable (59% compared with
61%, respectively; Table 3). However, nearly 22% (6/27)
of abstract conclusions had a high level of spin com-
pared with 11% (3/28) of main text conclusions. We
noted that in the main text conclusions, authors were
more likely to acknowledge the non-significance of
results and/or recommend further trials, thus reducing
the level of spin.
Cohort A: prevalence of spin by funding type
The source of funding could be determined for 82% of
trials (23/28; Table 4) with an even distribution of for
profit and not for profit funding (36%; 10/28 and 36%;
10/28, respectively).
Table 4 shows whether there was spin in the main text
and abstract conclusions, stratified by funding source.
Originally, inferential analysis was planned to investigate
the influence of funding, but due to the small sample
size it was decided to present only a descriptive analysis.
In total, 89% (8/9) of the industry funded trials had some
Table 1 Cohort A: summary of study characteristics
Characteristics Number (%)
n = 28
Funding
Not for profit 10 (35.7)
For profit 9 (32.1)
Mixed (not for profit and for profit) 4 (14.3)
Not reported 3 (10.7)
Unclear 2 (7.1)
Type of Wound
Leg ulcer 11 (39.3)
Diabetic foot ulcer 10 (35.7)
Pressure ulcer 6 (21.4)
Mixed ulcers 1 (3.6)
Intervention
Device 13 (46.4)
Drug 10 (35.7)
Surgery 3 (10.7)
Care management 2 (7.1)
Comparator
Placebo 7 (25.0)
Usual care 5 (17.9)
Device 12 (42.9)
Drug 2 (7.1)
Surgery 1 (3.6)
Care management 1 (3.6)
Duration of follow-up Median (IQR) Range
Weeks 12 [8-23] (3–156)
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element of spin in the abstract conclusions and 90%
(9/10) had some element of spin in the main text con-
clusions. This was somewhat higher than the prevalence
of spin observed in not-for-profit funded studies where
60% (6/10) had some element of spin in the abstract and
50% (5/10) had spin in the main text. However, only
25% (1/4) of reports of trials with mixed funding (that is
both for profit and not for profit) had some element of
spin in the abstract conclusions and 50% (2/4) in the
main text conclusions.
Cohort B: studies with no specified primary outcome
Cohort B comprised 43 studies representing 33% (43/132)
of identified RCTs of treatments for leg, foot and pressure
ulcers published between 2004 and 2009 in English
language journals (Table 5) (Additional file 1).
In the 43 studies comprising Cohort B, a median of 9
individual outcomes (IQR 6–16) were reported in the
main text results and a median of 3 (IQR 2–5) in the
Table 2 Cohort A: prevalence and type of spin by main text by section
Dichotomous
outcomes
Continuous
outcomes
All studies
Number (%) Number (%) Number (%)
n = 13 n = 15 n = 28
Results – any type* 4 (30.8) 4 (26.7) 8 (28.6)
Focus on statistically significant results from:
Within-group analyses 0 (0.0) 0 (0.0) 0 (0.0)
Subgroups 4 (30.8) 3 (20.0) 7 (25.0)
Secondary outcomes 0 (0.0) 3 (20.0) 3 (10.7)
Per protocol analysis 2 (15.4) 1 (6.7) 3 (10.7)
Other 1 (7.7) 0 (0.0) 1 (3.6)
Discussion – any type 8 (61.5) 8 (53.3) 16 (57.1)
Focus on statistically significant results from:
Within-group analyses 0 (0.0) 0 (0.0) 0 (0.0)
Subgroups 4 (30.8) 4 (26.7) 8 (28.6)
Secondary outcomes 0 (0.0) 5 (33.3) 5 (17.9)
Per protocol analysis 2 (15.4) 1 (6.7) 3 (10.7)
Claims equivalence 0 (0.0) 0 (0.0) 0 (0.0)
Rules out adverse effect 1 (7.7) 5 (33.3) 6 (21.4)
Other 5 (38.5) 0 (0.0) 5 (17.9)
Conclusions – any type 7 (53.8) 10 (66.6) 17 (60.7)
Claims effectiveness with no acknowledgement of NS results for primary outcome 4 (30.8) 4 (26.7) 8 (28.6)
Claims equivalence 1 (7.7) 5 (33.3) 6 (21.4)
Rules out adverse effect 0 (0.0) 0 (0.0) 0 (0.0)
Acknowledges non-significance, but emphasizes significant results for other outcomes 3 (23.1) 4 (26.7) 7 (25.0)
Acknowledges non-significance, but emphasizes treatment benefit 2 (15.4) 3 (20.0) 5 (17.9)
Emphasizes benefit based on new outcome 1 (7.7) 3 (20.0 4 (14.3)
Other 0 (0.0) 0 (0.0) 2 (7.1)
*More than one type could be used in each section of a report. NS, non-significant.
Table 3 Cohort A: level of spin in abstract and main text
conclusion sections
Level Number(%) Number(%)
Abstract conclusions Main text conclusions
n = 27 n = 28
None 11 (40.7) 11 (39.3)
Low 4 (14.8) 4 (14.3)
Moderate 6 (22.0) 10 (35.7)
High 6 (22.0) 3 (10.7)
Table 4 Cohort A: prevalence of spin by funding source
Funding source Number(%) Number(%)
Spin in abstract
conclusions
Spin in main text
conclusions
n = 27 n = 28
For profit (abstract n = 9;
main n =10)
8 (88.9) 9 (90.0)
Mixed (n = 4) 1 (25.0) 2 (50.0)
Not for profit (n = 10) 6 (60.0) 5 (50.0)
Unclear/Not reported (n = 4) 1 (25.0) 1 (25.0)
Total 17 (63.0) 16 (57.1)
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abstract results, compared to Cohort A where there were
a median of 4 (IQR 2–7) outcomes reported in the main
text results and a median of 2 (IQR 2–4) in the abstract
results.
Cohort B: influence of statistical significance on reporting
in the absence of a specified primary outcome
In total, 72% (31/43) of main text results in Cohort B in-
cluded at least one statistically significant result and 74%
(32/43) at least one statistically non-significant outcome
(Table 6). Fewer abstracts contained at least one statisti-
cally significant result (51%; 22/43); however, only 28%
of abstracts (12/43) contained at least one statistically
non-statistically significant outcome.
Cohort B: proportion of studies claiming a treatment
effect in the abstract conclusions
In Cohort B, 86% (37/43) of abstracts claimed a favo-
rable treatment effect (Table 7). Of these abstracts, 41%
(15/37) presented either no statistical analysis or only
statistically non-significant findings in support of the
claim. A further 41% (15/37) of the abstracts presented
only statistically significant results, even though many of
these trials presented both statistically significant and
non-significant findings in the main text (Table 6).
Discussion
This study is the first to appraise the prevalence of spin
in reports of trials of interventions for foot, leg or pres-
sure ulcers. A key finding was that a third of the wound
trial reports did not specify a primary outcome, a figure
comparable with that reported in the general medical
literature [5].
Key findings for studies with a statistically non-significant
difference for the primary outcome result (Cohort A)
We found that, as in general medical journals, spin is
commonly employed in reports of wound trials where
there is no statistically significant result for the primary
outcome. We found the lowest prevalence of spin in the
results sections of the main text and the highest in dis-
cussion and conclusion sections. Boutron and colleagues
[5] reported that 33% of general medical journal abs-
tracts contained a high level of spin in the conclusions,
whilst we report a prevalence of 22% with 59% of ab-
stract conclusions having some level of spin. We identi-
fied spin in reports of wound research funded by both
for-profit and not-for-profit agencies but did not have a
large enough sample to determine whether a significant
association with type of funding is associated with spin.
Table 5 Cohort B: summary of study characteristics
Characteristics Number (%)
n = 43
Funding
Not for profit 10 (23.3)
For profit 11 (25.6)
Mixed (not for profit and for profit) 2 (4.7)
Not reported 20 (45.6)
Unclear 0 (0.0)
Type of Wound
Leg ulcer 24 (55.8)
Diabetic foot ulcer 13 (30.2)
Pressure ulcer 5 (11.6)
Mixed ulcers 1 (2.3)
Intervention
Device 28 (65.1)
Drug 12 (27.9)
Surgery 1 (2.3)
Care management 2 (4.7)
Comparator (note, in trials >2 arms
there is >1 comparator)
n = 51
Placebo 19 (37.3)
Usual care 8 (15.7)
Device 17 (33.3)
Drug 4 (7.8)
Surgery 2 (3.9)
Care management 1 (2.0)
Duration of follow up Median (IQR) Range
Weeks 8 (4–13) 2–104
Table 6 Cohort B: comparison between the statistical significance of results presented in the main text results section
and abstract results section of reports with unclear primary outcome
Corresponding abstract results; number containing:
Main text results; number of reports containing: Outcomes with no reference to statistical
significance (n =16 including 3 with no abstract)
SS only
(n = 15)
SNS only
(n = 5)
SS and SNS
(n = 7)
Row A: Outcomes with no reference to statistical
significance (n = 6)
100% (6) 0% (0) 0% (0) 0% (0)
Row B: SS only (n = 5) 0% (0) 100% (5) 0% (0) 0% (0)
Row C: SNS only (n = 6) 33% (2) 0% (0) 50% (3) 17% (1)
Row D: SS and SNS (n = 26) 31% (8) 39% (10) 8% (2) 23% (6)
SNS, statistically non-significant; SS statistically significant.
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Further conclusions regarding the role of the funder are
therefore not possible on the basis of this study.
Key findings for studies with no specified primary
outcome (Cohort B)
Where studies did not clearly specify a primary outcome,
there is potential for spin in the form of emphasizing
study results based on the results of significance testing ra-
ther than the importance of the outcome. Our findings
suggest that such ‘cherry picking’ of statistically significant
results is common place in wound care trials with no clear
primary outcome. We found a discontinuity in the propor-
tions of statistically significant and non-significant results
reported between main texts and their corresponding
abstracts. Whilst in the main text nearly three-quarters of
reports included at least one statistically non-significant
result, only a quarter of abstracts contained at least one
non-significant result. Furthermore, whereas statistically
significant results from the main text results always appear
in the abstract, only a third of non-significant results did
so. This seems to provide evidence of selective presenta-
tion of statistically significant findings in study abstracts.
Importance of findings
Recent work on outcome reporting bias has largely fo-
cused on the selective reporting of a subset of outcomes
from the full set measured; in other words, a discrepancy
between study protocols and reports [3,4]. Other studies
have shown how high proportions of trial abstracts and
main text fail to meet international reporting standards
such as CONSORT (Consolidated Standards of Repor-
ting Trials), especially with respect to the reporting of
methodological information [22]. Our study lends fur-
ther support to the notion that spin is a major issue,
with abstracts being particularly prone to distorted pres-
entation of findings. Where there is no clear primary
outcome specified, there is also evidence that distortion
of findings in the main text emphasizes the benefits of
treatments based on selected use of evidence. Such dis-
cordance between report sections of trials has also re-
cently been noted when comparing abstract conclusions
with main text conclusions — with stronger statements
of support for treatments in the abstract [23].
Distorted reporting in abstracts is of particular con-
cern as these sections are easily accessed (and freely
available), so clinical decisions may be based on abs-
tracts alone [24]. Even when the full report is available,
readers may only scan the abstract and conclusions
[12,25]. These issues are of particular relevance in wound
care, an area of healthcare where many of the treatment
decisions are made by nurses working in community set-
tings, where there are significant time constraints and
limited access to computers and research findings.
Limitations
When determining whether the results of the inclu-
ded studies were statistically significant or not, we used
P < 0.05/≥ 0.05 as the criterion. We recognize that,
generally, trial outcomes should not be judged or inter-
preted solely on this cut-off. We note that our applica-
tion of this cut-off reflects reporting practice within the
included studies as well as general interpretation of sta-
tistical findings.
We also note that the first screening phase of this
work (study titles and abstracts) was only conducted by
one reviewer. Ideally this should have been undertaken
by two reviewers but this was not possible at the time.
The single reviewer was very experienced in conducting
systematic reviews in the field and also took a conserva-
tive approach, meaning she included all the studies
where there was doubt as to eligibility and these were
retrieved as full text. Two reviewers were involved in the
second stage sifting of the full text of studies, as
highlighted by the large number of studies (approxi-
mately 100) that were excluded at that stage.
The methodology for Cohort A was based on a pub-
lished classification of spin, but beyond Boutron and col-
leagues [5] there is no further guidance on its use, so the
methods we adopted may have differed in practice. How-
ever, we found application of Boutron and colleagues [5]
methods viable and using this previous work meant find-
ings from this work could be related to a general cohort of
trial reports. However, as noted by Boutron and colleagues
[5], the assessment of spin has a subjective element. To
minimize any negative effects of such subjectivity we
undertook detailed preparatory work regarding the iden-
tification and classification of spin in order to try and
harmonize the process. As such, agreement between the
two independent reviewers was found to be fair to good.
Due to incomplete reporting we were not able to classify
Table 7 Cohort B: use of statistical testing to support claims of effectiveness in trial reports
Abstract results section
Claim effectiveness in abstract? No reference to statistical significance
(n =16 including 3 with no abstract)
SNS only (n = 5) SS only (n = 15) SS and SNS (n = 7)
Yes (n = 37; 86%) 32% (12) 8% (3) 41% (15) 19% (7)
No (n = 3; 7%) 33% (1) 67% (2) 0% (0) 0% (0)
No Abstract (n = 3; 7%) 100% (3) 0% (0) 0% (0) 0% (0)
SNS, statistically non-significant; SS, statistically significant.
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the source of funding for a number of studies. It is likely
that the non-reporting of funding is not random and may
represent a potential source of bias. Finally, whilst the
sample size for Cohort A was small, limiting possible ana-
lysis of factors which may influence spin, we note this
does reflect all trial report evidence available to us over
the period of interest.
The second part of the study (Cohort B) was explora-
tory; data extraction was therefore limited to the results
and conclusions sections to identify the number of out-
comes and the conclusions drawn. The study was based
on outcomes reported in the results section only and
trial protocols were not checked.
Conclusions
We have demonstrated for the first time that a large
proportion of the reports of interventions for foot, leg or
pressure ulcers are affected by “spin”. We have also de-
monstrated that a high proportion of wound trials do
not specify a primary outcome and these seem to selec-
tively present outcomes, perhaps based on the results of
significance testing.
Given the high proportion of papers that contain spin,
end-users of wound care research need to be aware of
the types of spin used and should approach papers with
a clear sense of which outcomes are important to them
(and particularly, patients). Readers should be wary of pa-
pers which do not clearly present important outcomes
such as healing in both the results and conclusions. Rea-
ders should avoid relying on the abstract as a reliable re-
port of a wound care trial. Critical appraisal skills training
for all users of research is potentially beneficial as way of
combating the impact of spin on clinical decision making.
Investigators, editors and peer reviewers need awareness
of the issue of spin and the importance of objectivity in
research reporting. There is also scope for further research
into both trial reports which do not define a primary
outcome and in particular the impact on end-users.
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